{"id":15278,"date":"2021-06-10T14:13:26","date_gmt":"2021-06-10T12:13:26","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=15278"},"modified":"2021-06-10T14:13:26","modified_gmt":"2021-06-10T12:13:26","slug":"association-ruxolitinib-venetoclax-dans-la-leucemie-prolymphocytaire-t-une-association-prometteuse","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/association-ruxolitinib-venetoclax-dans-la-leucemie-prolymphocytaire-t-une-association-prometteuse\/","title":{"rendered":"Association ruxolitinib + v\u00e9n\u00e9toclax dans la leuc\u00e9mie prolymphocytaire T : une association prometteuse"},"content":{"rendered":"<p>R\u00e9f. :HematoStat.net ; 1 (1) : V7<\/p>\n<p><a href=\"https:\/\/www.sciencedirect.com\/journal\/blood\/vol\/137\/issue\/25\"><em>Herbaux C, Kornauth C, Poulain S, Chong SJF, Collins MC, Valentin R, Hackett L, Tournilhac O, Lemonnier F, Dupuis J, Daniel A, Tomowiak C, Laribi K, Renaud L, Roos-Weil D, Rossi C, Van Den Neste E, Leyronnas C, Merabet F, Malfuson JV, Tiab M, Ysebaert L, Ng S, Morschhauser F, Staber PB, Davids MS. BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. Blood. 2021 Jun 24;137(25):3495-3506. doi: 10.1182\/blood.2020007303. PMID: 33598678.<\/em><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>R\u00e9f. :HematoStat.net ; 1 (1) : V7 Herbaux C, Kornauth C, Poulain S, Chong SJF, Collins MC, Valentin R, Hackett L, Tournilhac O, Lemonnier F, Dupuis J, Daniel A, Tomowiak [&hellip;]<\/p>","protected":false},"author":2,"featured_media":15279,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[11],"tags":[158,159,160],"ppma_author":[442],"class_list":["post-15278","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-veille-bibliographique","tag-leucemie-prolymphocytaire-t","tag-ruxolitinib","tag-venetoclax","author-marion"],"aioseo_notices":[],"authors":[{"term_id":442,"user_id":2,"is_guest":0,"slug":"marion","display_name":"HematoStat.net (M)","avatar_url":{"url":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png","url2x":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png"},"first_name":"HematoStat.net (M)","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=15278"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15278\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=15278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=15278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=15278"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=15278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}